Athersys Inc

4LS-FF:Frankfurt Stock Exchange
RT Quote | Exchange | EUR
Last | 9:11 AM CET
1.72quote price arrow down-0.07 (-3.91%)
52 week range
1.27 - 1.79

...

Loading . . .

KEY STATS

  • Open1.72
  • Day High1.72
  • Day Low1.72
  • Prev Close1.79
  • 52 Week High1.79
  • 52 Week High Date01/26/21
  • 52 Week Low1.27
  • 52 Week Low Date01/04/21
  • Market Cap383.32M
  • Shares Out197.59M
  • 10 Day Average Volume1,339.27
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change42.15

RATIOS/PROFITABILITY

  • EPS (TTM)-0.32
  • P/E (TTM)-5.38
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Athersys Inc News

There is no recent news for this security.

Latest 4LS-FF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of...
Gil Van Bokkelen Ph.D.
Chairman
William Lehmann Jr. J.D.
President
Ivor Macleod
Chief Financial Officer
John Harrington Ph.D.
Executive Vice President
Address
3201 Carnegie Ave
Cleveland, OH
44115-2634
United States